Join us for a compelling deep dive into the latest advancements in pediatric diabetes care. This special edition highlights the results of the INHALE-1 trial, a milestone study evaluating the use of inhaled Technosphere insulin in children with type 1 diabetes.
🗓 Date: December 16, 2025 ⏰ Time: 17:00 (Kyiv)
This event is supported by MannKind Corporation.
Workshop Highlights
- Topic: “INHALE-1: A Multi-center Randomized Trial of Inhaled Technosphere Insulin in Children with Type 1 Diabetes”
- Date & Time: Tuesday, 16 December, at 16:00 CET
- Duration: 1 Hour
- Speakers: Sabina Poenar, Roy W. Beck, MD, PhD and Michael James Haller
Don’t miss this opportunity to gain practical insights and clinical pearls from leading experts.
Moderator

Sabina Poenar
Resident doctor- diabetes, nutrition and metabolic diseases, County Emergency Hospital Brasov
Speakers

Roy W. Beck, MD, PhD
JAEB Center for Health Research
Roy W. Beck, MD, PhD is a physician and epidemiologist with more than 35 years’ experience directing and coordinating multi-center clinical trials. He is the Medical Director of the Jaeb Center for Health Research, which he founded in 1993. During the last 20+ years, he has had a leadership role in numerous CGM, automated insulin delivery systems, and drug studies funded by NIH, JDRF, the Helmsley Charitable Trust, and industry. Dr. Beck has been an author or co-author of more than 500 manuscripts in scientific journals.

Michael James Haller
Professor and Chief, Pediatric Endocrinology, University of Florida
Michael Haller is Professor and Chief of Pediatric Endocrinology at the University of Florida. His work focuses on the prediction, prevention, and reversal of beta cell decline in type 1 diabetes. He has served as the study PI for the pediatric inhaled insulin PK/PD studies as well as the RCT for the use of inhaled insulin in children with diabetes.
After the Webinar
After the webinar, you will be able to access the on-demand recording on the ATTD Educational Portal along with a CME/CPD accredited activity.

Sabina Poenar is a resident physician in Diabetes, Nutrition, and Metabolic Diseases at the County Emergency Hospital Brașov, Romania. Her clinical focus includes personalized nutrition, advanced therapies, and technology-enabled strategies for diabetes prevention and management, with a particular interest in obesity as a comorbidity. She has contributed to international congresses, clinical trials, and health innovation projects, translating research insights into precision approaches in clinical practice.